These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9631473)

  • 1. The role of CRF2 receptors in corticotropin-releasing factor- and urocortin-induced anorexia.
    Smagin GN; Howell LA; Ryan DH; De Souza EB; Harris RB
    Neuroreport; 1998 May; 9(7):1601-6. PubMed ID: 9631473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity.
    Zorrilla EP; Reinhardt LE; Valdez GR; Inoue K; Rivier JE; Vale WW; Koob GF
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1027-34. PubMed ID: 15115804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of corticotropin-releasing factor type 1 (CRF1) receptor messenger ribonucleic acid in the paraventricular nucleus of rat hypothalamus by exogenous CRF.
    Mansi JA; Rivest S; Drolet G
    Endocrinology; 1996 Nov; 137(11):4619-29. PubMed ID: 8895325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of urocortin 2 and 3 on motor activity and food intake in rats.
    Ohata H; Shibasaki T
    Peptides; 2004 Oct; 25(10):1703-9. PubMed ID: 15476937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of lateral septum CRF2 receptors promotes anorexia and stress-like behaviors: functional homology to CRF1 receptors in basolateral amygdala.
    Bakshi VP; Newman SM; Smith-Roe S; Jochman KA; Kalin NH
    J Neurosci; 2007 Sep; 27(39):10568-77. PubMed ID: 17898228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence supporting a role for corticotropin-releasing factor type 2 (CRF2) receptors in the regulation of subpopulations of serotonergic neurons.
    Staub DR; Evans AK; Lowry CA
    Brain Res; 2006 Jan; 1070(1):77-89. PubMed ID: 16403469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system.
    Hashimoto K; Nishiyama M; Tanaka Y; Noguchi T; Asaba K; Hossein PN; Nishioka T; Makino S
    Peptides; 2004 Oct; 25(10):1711-21. PubMed ID: 15476938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticotropin-releasing factor (CRF) and the urocortins differentially regulate catecholamine secretion in human and rat adrenals, in a CRF receptor type-specific manner.
    Dermitzaki E; Tsatsanis C; Minas V; Chatzaki E; Charalampopoulos I; Venihaki M; Androulidaki A; Lambropoulou M; Spiess J; Michalodimitrakis E; Gravanis A; Margioris AN
    Endocrinology; 2007 Apr; 148(4):1524-38. PubMed ID: 17194738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor 1 deficiency in mice.
    Bradbury MJ; McBurnie MI; Denton DA; Lee KF; Vale WW
    Endocrinology; 2000 Aug; 141(8):2715-24. PubMed ID: 10919255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the nociceptin/orphanin FQ system is unable to reverse CRF2 receptor mediated anorexia in the rat.
    Fedeli A; Policani F; Ubaldi M; Cippitelli A; Massi M; Ciccocioppo R
    Peptides; 2006 Dec; 27(12):3284-91. PubMed ID: 17050037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urocortin shares the memory modulating effects of corticotropin-releasing factor (CRF): mediation by CRF1 receptors.
    Zorrilla EP; Schulteis G; Ormsby A; Klaassen A; Ling N; McCarthy JR; Koob GF; De Souza EB
    Brain Res; 2002 Oct; 952(2):200-10. PubMed ID: 12376180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediation of burn-induced hypermetabolism by CRF receptor-2 activity.
    Chance WT; Dayal R; Friend LA; Thomas I; Sheriff S
    Life Sci; 2007 Feb; 80(11):1064-72. PubMed ID: 17222429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.
    Fekete EM; Inoue K; Zhao Y; Rivier JE; Vale WW; Szücs A; Koob GF; Zorrilla EP
    Neuropsychopharmacology; 2007 May; 32(5):1052-68. PubMed ID: 17019404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral administration of CRF and urocortin: effects on food intake and the HPA axis in the marsupial Sminthopsis crassicaudata.
    Hope PJ; Turnbull H; Farr S; Morley JE; Rice KC; Chrousos GP; Torpy DJ; Wittert GA
    Peptides; 2000 May; 21(5):669-77. PubMed ID: 10876049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central CRF, urocortins and stress increase colonic transit via CRF1 receptors while activation of CRF2 receptors delays gastric transit in mice.
    Martínez V; Wang L; Rivier J; Grigoriadis D; Taché Y
    J Physiol; 2004 Apr; 556(Pt 1):221-34. PubMed ID: 14755002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
    Kageyama K; Kimura R; Suga S; Ogawa Y; Suda T; Wakui M
    Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic urocortin 2, but not urocortin 1 or stressin 1-A, suppresses feeding via CRF2 receptors without malaise and stress.
    Fekete EM; Zhao Y; Szücs A; Sabino V; Cottone P; Rivier J; Vale WW; Koob GF; Zorrilla EP
    Br J Pharmacol; 2011 Dec; 164(8):1959-75. PubMed ID: 21627635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous expression and in vitro study of CRF-related peptides and CRF receptors in the rat gastric antrum.
    Porcher C; Peinnequin A; Pellissier S; Meregnani J; Sinniger V; Canini F; Bonaz B
    Peptides; 2006 Jun; 27(6):1464-75. PubMed ID: 16337313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice.
    Risbrough VB; Hauger RL; Pelleymounter MA; Geyer MA
    Psychopharmacology (Berl); 2003 Nov; 170(2):178-87. PubMed ID: 12845406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists.
    de Groote L; Peñalva RG; Flachskamm C; Reul JM; Linthorst AC
    J Neurochem; 2005 Jul; 94(1):45-56. PubMed ID: 15953348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.